Curaleaf: The Analyst Take On The European Expansion
On April 7th, Curaleaf Holdings (CSE: CURA) announced that they completed $312 million acquisition of related party European company EMMAC
Read moreOn April 7th, Curaleaf Holdings (CSE: CURA) announced that they completed $312 million acquisition of related party European company EMMAC
Read moreCuraleaf Holdings (CSE: CURA) this morning announced the completion of EMMAC Life Sciences, a vertically integrated cannabis firm in Europe.
Read moreThe outbreak of COVID-19 threw a wrench into the plans of many companies who were forced to shelve their growth
Read moreCuraleaf Holdings (CSE: CURA) this evening reported total revenue of $230.3 million for the fourth quarter of 2020, an increase
Read moreCuraleaf Holdings (CSE: CURA) this evening announced that it is making a move into European markets. The US-focused cannabis operator
Read moreCuraleaf Holdings (CSE: CURA) announced that they will be reporting their fourth quarter and year-end financials post-market on March 9th. Analysts
Read moreMarch is turning out to be a busy month in public cannabis, with many of the prominent U.S cannabis names
Read moreWelcome to the Deep Dive Video Essay Series. Today we are looking at US Cannabis. Okay, so with the Senate
Read moreCuraleaf Holdings (CSE: CURA) this morning achieved a milestone, with company opening its 100th national retail location within the US.
Read moreWednesday, Canaccord came out with their updated valuations for the large three multi-state operators. In doing so, they raised their
Read more